Friday, 11 June 2021 19:51

Anticoagulation news items. Weeks commencing 31st May 2021 & 7th June 2021

Updated COVID-19 vaccination guidance: blood clotting information for healthcare professionals

Public Health England
This guidance has been updated to include antiphospholipid syndrome, interchangeability of COVID-19 vaccines, samples required for whole genome sequencing and the latest MHRA data.


Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

British Medical Journal
RCT (n=1471, Canada & India) found that in patients with AF or mechanical heart valves who had warfarin interrupted for a procedure, no significant benefit was found for postop dalteparin bridging to prevent major thromboembolism (occurred in 1.0% vs. 1.2% placebo within 90 days).



The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at: